<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04652687</url>
  </required_header>
  <id_info>
    <org_study_id>VIV-001-020</org_study_id>
    <nct_id>NCT04652687</nct_id>
  </id_info>
  <brief_title>Discogenic Low Back Pain Registry</brief_title>
  <official_title>Discogenic Low Back Pain Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vivex Biomedical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Talosix</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vivex Biomedical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Registry is to observe and trend patterns of care and outcomes for the standard of care&#xD;
      treatments of discogenic chronic LBP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Discogenic Low Back Pain (LBP) Registry is intended to complement and integrate data&#xD;
      collected in ongoing randomized-controlled clinical studies to aid in establishing payor&#xD;
      coverage in the United States (US) for VIA Disc NP with real-world data. This registry will,&#xD;
      in turn, further assist in establishing a health economics argument for use of VIA Disc NP in&#xD;
      medical facilities for US payors and provide real-world data to support ongoing quality for&#xD;
      care initiatives.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2020</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>36 Months</target_duration>
  <primary_outcome>
    <measure>Patient self-reporting of overall health</measure>
    <time_frame>1, 3, 6, 12, 24, &amp; 36 months</time_frame>
    <description>Change in scores from Patient Reported Outcomes Measurement Information System (PROMIS-10). 10-item questionnaire used to assess general domains of health and function, including overall physical health, mental health, social health, pain, fatigue and overall perceived quality of life.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient self-reporting of daily function</measure>
    <time_frame>1, 3, 6, 12, 24, &amp; 36 months</time_frame>
    <description>Change in scores from Oswestry Disability Index (ODI). An index comprising of ten categories of function to quantify disability due to low back pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient self-reported back pain</measure>
    <time_frame>1, 3, 6, 12, 24, &amp; 36 months</time_frame>
    <description>Change in Numeric Rating Scale (NRS) scores. Eleven point pain scale used for patient self-reporting of back pain, which ranges from 0 (no pain) to 10 (the worst pain imaginable).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Employment Status</measure>
    <time_frame>1, 3, 6, 12, 24, &amp; 36 months</time_frame>
    <description>Patient reported return to work - same or different capacity answers to employment questions will be assessed across time points and compared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource Utilization</measure>
    <time_frame>1, 3, 6, 12, 24, &amp; 36 months</time_frame>
    <description>Patient reported assessment of healthcare and resources utilized questions to treat ongoing discogenic low back pain post treatment.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Discogenic Pain</condition>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>VIA Disc NP</arm_group_label>
    <description>Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment for discogenic low back pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non Surgical Management</arm_group_label>
    <description>Patients receiving non surgical management (i.e., physical therapy, transforaminal epidural steroid injection, lifestyle modification, or surgical intervention)</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>VIA Disc NP</intervention_name>
    <description>VIA Disc NP - Allograft tissue injection</description>
    <arm_group_label>VIA Disc NP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Transforaminal Epidural steroid injection</intervention_name>
    <description>epidural injection of steroid into the affected area of low back pain</description>
    <arm_group_label>Non Surgical Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle modification</intervention_name>
    <description>physician instructed changes to patient's daily activities to alleviate low back pain</description>
    <arm_group_label>Non Surgical Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical therapy</intervention_name>
    <description>Physician ordered physical therapy and exercises to alleviate low back pain</description>
    <arm_group_label>Non Surgical Management</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Registry will include at least 1,000 patients diagnosed with and treated for discogenic low&#xD;
        back pain across approximately 40 selected sites.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Understand and sign the informed consent form (as applicable)&#xD;
&#xD;
          -  Discogenic Low Back pain diagnosis made and/or confirmed at participating site based&#xD;
             on:&#xD;
&#xD;
          -  Axial low back pain and discomfort&#xD;
&#xD;
          -  Sitting intolerance&#xD;
&#xD;
          -  Increased pain with bending forward, sustained hip flexion and compression&#xD;
&#xD;
          -  Pain is less with lying down or hip extension&#xD;
&#xD;
          -  Evidence of degenerated lumbar disc on MRI&#xD;
&#xD;
          -  Minimum of six (6) months prior non-surgical management&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Disc extrusions or sequestration&#xD;
&#xD;
          -  Symptomatic spinal stenosis&#xD;
&#xD;
          -  Spondylolsthesis of grade 2 or higher&#xD;
&#xD;
          -  Lumbar spondylitis&#xD;
&#xD;
          -  Vertebral compression fracture at any level&#xD;
&#xD;
          -  Any medical condition that impairs follow-up (i.e., fibromyalgia, rheumatoid&#xD;
             arthritis, chronic regional pain syndrome, reflex sympathetic dystrophy) Evidence of&#xD;
             substance abuse or patients using prescribed extended-release narcotics (e.g.,&#xD;
             fentanyl patch, MS Contin, oxycontin) within 3 months prior to screening&#xD;
&#xD;
          -  Evidence of mental instability (bipolar disorders, post-traumatic stress disorder&#xD;
             (PTSD) or uncontrolled anxiety/depression); requiring new or any change in&#xD;
             anti-depressants or anti-psychotic medications; or in opinion of the investigator is&#xD;
             not a reliable candidate&#xD;
&#xD;
          -  Discogenic Low Back Pain is due to worker's compensation and/or a personal injury&#xD;
             case. Litigation is occurring or expected during study participation.&#xD;
&#xD;
          -  Altered mental status or any language barriers that would prevent completion of the&#xD;
             patient reported outcome surveys after the procedure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>J Kenneth Burkus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>J Ken Burkus MD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lisa Finstein, MHA</last_name>
    <phone>(888) 684-7783</phone>
    <email>lfinstein@vivex.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gateway Pain Solutions</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gladys Higgs</last_name>
      <phone>480-924-7091</phone>
      <phone_ext>342</phone_ext>
      <email>ghiggs@gatewaypainaz.com</email>
    </contact>
    <investigator>
      <last_name>Matthew Ransom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Source Healthcare</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Afrida Sara</last_name>
      <phone>310-574-2777</phone>
      <email>asara@sourcehealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Timothy Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Interventional Pain Management</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley S Gonzalez</last_name>
      <phone>925-478-5490</phone>
      <email>agonzalez2@ipmdoctors.com</email>
    </contact>
    <investigator>
      <last_name>Kasra Amirdelfan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>International Spine, Pain &amp; Performance Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sidrah Sheikh, MS</last_name>
      <phone>202-808-8295</phone>
      <phone_ext>109</phone_ext>
      <email>ssheikh@isppcenter.com</email>
    </contact>
    <investigator>
      <last_name>Mehul Desai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FAST MD</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa King</last_name>
      <phone>813-533-7080</phone>
    </contact>
    <contact_backup>
      <last_name>Johnny Gacio</last_name>
      <phone>8135337080</phone>
    </contact_backup>
    <investigator>
      <last_name>Farhan Siddiqi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Research Foundation</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46278</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Glover</last_name>
      <phone>317-802-2880</phone>
      <email>mglover@orthoindy.com</email>
    </contact>
    <investigator>
      <last_name>Meredith Langhorst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michigan Interventional Pain Center</name>
      <address>
        <city>Brownstown</city>
        <state>Michigan</state>
        <zip>48183</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Forest Health</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <zip>48198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Lockhart</last_name>
      <phone>734-547-4868</phone>
      <email>mlockhart@foresthealth.com</email>
    </contact>
    <investigator>
      <last_name>John Chatas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nevada Advanced Pain Specialists</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacy Gomez</last_name>
      <phone>775-284-8650</phone>
      <email>research@nvadvancedpain.com</email>
    </contact>
    <investigator>
      <last_name>Denis G Patterson, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ainsworth Institute of Pain Management</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kumar Sigra</last_name>
      <phone>212-203-2813</phone>
      <email>ksigra@ainpain.com</email>
    </contact>
    <investigator>
      <last_name>Corey W Hunter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Premier Pain</name>
      <address>
        <city>Loveland</city>
        <state>Ohio</state>
        <zip>45140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mandi Colwell</last_name>
      <phone>513-454-7246</phone>
      <email>mcolwell1@premierpaintreatment.com</email>
    </contact>
    <investigator>
      <last_name>Michael Danko, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Invictus Healthcare System</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Austin</last_name>
      <phone>918-994-4055</phone>
      <email>jaustin@invictus.healthcare</email>
    </contact>
    <investigator>
      <last_name>Gregory L Wilson, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 3, 2020</study_first_submitted>
  <study_first_submitted_qc>December 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>low back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

